|
|
Leading Article |
| Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements |
1639 |
| S Sitailo,
R Sood,
K Barton & G Nucifora
|
|
Abstract
Full Article (PDF)
|
|
Reviews |
| Chronic myeloid leukemia from basics to bedside |
1646 |
| SFT Thijsen,
GJ Schuurhuis,
JW van Oostveen & GJ Ossenkoppele
|
|
Abstract
Full Article (PDF)
|
|
| The role of Homeobox genes in normal hematopoiesis and hematological malignancies |
1675 |
| JW van Oostveen,
JJ Bijl,
FM Raaphorst,
JJM Walboomers & CJLM Meijer
|
|
Abstract
Full Article (PDF)
|
|
| Clinical relevance of minimal residual disease monitoring in non-Hodgkin’s lymphomas: a critical reappraisal of molecular strategies |
1691 |
| P Corradini,
M Ladetto,
A Pileri & C Tarella
|
|
Abstract
Full Article (PDF)
|
|
Original Manuscripts |
| Childhood ALL, Prognosis |
| Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study |
1696 |
| J Pullen,
JJ Shuster,
M Link,
M Borowitz,
M Amylon,
AJ Carroll,
V Land,
AT Look,
B McIntyre & B Camitta
|
|
Abstract
Full Article (PDF)
|
|
| TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification |
1708 |
| KW Maloney,
L McGavran,
JR Murphy,
LF Odom,
L Stork,
Q Wei & SP Hunger
|
|
Abstract
Full Article (PDF)
|
|
| Detection of MLL gene rearrangement |
| Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities |
1713 |
| S Mathew,
FG Behm,
J Dalton & SC Raimondi
|
|
Abstract
Full Article (PDF)
|
|
| Atypical B Cell Leukemias: Diagnosis |
| FISH analysis for BCL-1 rearrangements and trisomy 12 helps the diagnosis of atypical B cell leukaemias |
1721 |
| E Matutes,
P Carrara,
L Coignet,
V Brito-Babapulle,
N Villamor,
A Wotherspoon & D Catovsky
|
|
Abstract
Full Article (PDF)
|
|
| MDS: Prognosis |
| New system for assessing the prognosis of refractory anemia patients |
1727 |
| A Matsuda,
I Jinnai,
F Yagasaki,
S Kusumoto,
I Murohashi,
M Bessho,
K Hirashima,
S Honda,
M Minamihisamatsu,
K Fuchigami,
T Matsuo,
K Kuriyama & M Tomonaga
|
|
Abstract
Full Article (PDF)
|
|
| Secondary AML |
| Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy |
1735 |
| JF Seymour,
SK Juneja,
LJ Campbell,
PH Ellims,
EH Estey & HM Prince
|
|
Abstract
Full Article (PDF)
|
|
| Myelofibrosis |
| Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - a clinicopathological study |
1741 |
| J Thiele,
HM Kvasnicka,
B Boeltken,
R Zankovich,
V Diehl & R Fischer
|
|
Abstract
Full Article (PDF)
|
|
| Clonality Studies in CML |
Extensive cytogenetic studies of clonality following interferon- therapy in chronic myeloid leukemia occurring in monosomic cells in a patient with Turner syndrome mosaic |
1749 |
| A Takeshita,
K Shinjo,
M Yamashita,
S Fujisawa,
K Naito,
K Ohnishi,
K Takahashi,
H Matsui & R Ohno
|
|
Abstract
Full Article (PDF)
|
|
| Molecular Cytogenetics |
| Molecular analysis of chromosomal breakpoints in three examples of chromosomal translocation involving the TEL gene |
1754 |
| SP Romana,
H Poirel,
V Della Valle,
M Mauchauffé,
M Busson-Le Coniat,
R Berger & OA Bernard
|
|
Abstract
Full Article (PDF)
|
|
| Tumor Suppressor Genes-Clinical Correlates |
| Expression of p16INK4A and p14ARF in hematological malignancies |
1760 |
| T Taniguchi,
N Chikatsu,
S Takahashi,
A Fujita,
K Uchimaru,
S Asano,
T Fujita & T Motokura
|
|
Abstract
Full Article (PDF)
|
|
| "Leukemicness" of Early Progenitors in AML |
| Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias |
1770 |
| C Brendel,
B Mohr,
C Schimmelpfennig,
J Müller,
M Bornhäuser,
M Schmidt,
M Ritter,
G Ehninger & A Neubauer
|
|
Abstract
Full Article (PDF)
|
|
| Gene Therapy |
| Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells - implications for chemoprotective gene therapy |
1776 |
| N Chinnasamy,
JA Rafferty,
LS Lashford,
D Chinnasamy,
GP Margison,
N Thatcher,
TM Dexter & LJ Fairbairn
|
|
Abstract
Full Article (PDF)
|
|
Open Forum |
| Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia |
1784 |
| MW Lensch,
RK Rathbun,
SB Olson,
GR Jones & GC Bagby Jr
|
|
Abstract
Full Article (PDF)
|
|
| Animal Models: Chronic Myeloproliferative Disorders |
The Tel-PDGFR fusion gene produces a chronic myeloproliferative syndrome in transgenic mice |
1790 |
| KA Ritchie,
AAG Aprikyan,
DF Bowen-Pope,
CJ Norby-Slycord,
S Conyers,
SH Bartelmez,
E Sitnicka & DD Hickstein
|
|
Abstract
Full Article (PDF)
|
|
| Lymphoma |
| Frequent allelic imbalance but infrequent microsatellite instability in gastric lymphoma |
1804 |
| MA Hoeve,
SC Ferreira Mota,
E Schuuring,
WJF de Leeuw,
A Chott,
JPP Meijerink,
PhM Kluin & JHJM van Krieken
|
|
Abstract
Full Article (PDF)
|
|
| Myeloma |
| Detection of MUM1/IRF4-IgH fusion in multiple myeloma |
1812 |
| S Yoshida,
N Nakazawa,
S Iida,
Y Hayami,
S Sato,
A Wakita,
S Shimizu,
M Taniwaki & R Ueda
|
|
Abstract
Full Article (PDF)
|
|
| TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells |
1817 |
| Y Gazitt
|
|
Abstract
Full Article (PDF)
|
|
Biotechnical Methods Section (BTS) |
| Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR |
1825 |
| M Emig,
S Saußele,
H Wittor,
A Weißer,
A Reiter,
A Willer,
U Berger,
R Hehlmann,
NCP Cross & A Hochhaus
|
|
Abstract
Full Article (PDF)
|
|
| Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD) |
1833 |
| K Olsson,
CJ Gerard,
J Zehnder,
C Jones,
R Ramanathan,
C Reading & EG Hanania
|
|
Abstract
Full Article (PDF)
|
|
| Quantitation of leukemia clone-specific antigen gene rearrangements by a single-step PCR and fluorescence-based detection method |
1843 |
| SP Mayer,
J Giamelli,
C Sandoval,
AS Roach,
M Fevzi Ozkaynak,
O Tugal,
G Rovera & S Jayabose
|
|
Abstract
Full Article (PDF)
|
|
Gieseler Papers On Apoptosis Research |
| Introduction |
| Apoptosis research is saving the reputation of chemotherapy |
1853 |
| F Gieseler & V Nuessler
|
|
Full Article (PDF)
|
|
Review |
| Gieseler Papers On Apoptosis Research |
| Cytotoxic drugs and the CD95 pathway |
1854 |
| C Friesen,
S Fulda & K-M Debatin
|
|
Abstract
Full Article (PDF)
|
|
Gieseler Papers On Apoptosis Research |
| Papers |
| Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage |
1859 |
| F Gieseler,
E Bauer,
V Nuessler,
M Clark & S Valsamas
|
|
Abstract
Full Article (PDF)
|
|
| Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines |
1864 |
| V Nuessler,
O Stötzer,
E Gullis,
R Pelka-Fleischer,
A Pogrebniak,
F Gieseler & W Wilmanns
|
|
Abstract
Full Article (PDF)
|
|
| Drug-induced apoptosis in chronic lymphocytic leukemia |
1873 |
| OJ Stoetzer,
A Pogrebniak,
M Scholz,
R Pelka-Fleischer,
E Gullis,
M Darsow,
V Nüssler & W Wilmanns
|
|
Abstract
Full Article (PDF)
|
|
| Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid |
1881 |
| M Andreeff,
S Jiang,
X Zhang,
M Konopleva,
Z Estrov,
VE Snell,
Z Xie,
MF Okcu,
G Sanchez-Williams,
J Dong,
EH Estey,
RC Champlin,
SM Kornblau,
JC Reed & S Zhao
|
|
Abstract
Full Article (PDF)
|
|
Correspondence |
| Two cases of very late relapsing ALL carrying the TEL:AML1 fusion gene |
1893 |
| CD Chow,
L Dalla-Pozza,
DJ Gottlieb & MS Hertzberg
|
|
Full Article (PDF)
|
|
| Mutations of the BCL10 gene are not associated with the blast crisis of chronic myeloid leukaemia |
1894 |
| S Bose,
JM Goldman & JV Melo
|
|
Full Article (PDF)
|
|
| Treatment of red cell aplasia in CLL with fludarabine |
1897 |
| I Ribeiro,
C Tsatalas & D Catovsky
|
|
Full Article (PDF)
|
|
| UV and clean air result in contamination-free PCR |
1898 |
| RA Padua,
A Parrado,
J Larghero & C Chomienne
|
|
Full Article (PDF)
|
|
